Orphan drug reauthorization
Subtitle: hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1994
Place of publication: Washington
Language: eng
Number of pages: 117
Subjects: Drugs -- Law and legislation -- United States; Orphan drugs -- United States; Pharmaceutical industry -- Research -- United States
Notes: Includes bibliographical references.
Distributed to some depository libraries in microfiche.
Shipping list no.: 94-0313-P.
"Serial no. 103-113."